{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:12:31Z","timestamp":1793283151348,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003524","name":"Ministry of Business, Innovation and Employment","doi-asserted-by":"publisher","award":["RTVU1503"],"award-info":[{"award-number":["RTVU1503"]}],"id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cellsig.2022.110449","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T13:00:20Z","timestamp":1661605220000},"page":"110449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Clozapine reduces chemokine-mediated migration of lymphocytes by targeting NF-\u03baB and AKT phosphorylation"],"prefix":"10.1016","volume":"99","author":[{"given":"Afnan","family":"Al Abadey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwen","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Camille La","family":"Flamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Robichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2022.110449_bb0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1212\/01.CON.0000433291.23091.65","article-title":"Pathology of multiple sclerosis: where do we stand?","volume":"19","author":"Popescu","year":"2013","journal-title":"Continuum"},{"key":"10.1016\/j.cellsig.2022.110449_bb0010","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbadis.2015.10.018","article-title":"Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke","volume":"1862","author":"Lopes Pinheiro","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.cellsig.2022.110449_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099068","article-title":"Early treatment with anti-VLA-4 mAb can prevent the infiltration and\/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE","volume":"9","author":"Mindur","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110449_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","article-title":"Clozapine as a model for antipsychotic development","volume":"14","author":"Nucifora","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/cn400189s","article-title":"Clozapine, a fast-off-D2 antipsychotic","volume":"5","author":"Seeman","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","article-title":"Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures","volume":"11","author":"Al-Amin","year":"2013","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0045","article-title":"Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis","volume":"3","author":"Green","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-020-01733-4","article-title":"Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis","volume":"17","author":"Robichon","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110449_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00210-012-0734-2","article-title":"Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism","volume":"385","author":"Vauquelin","year":"2012","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110449_bb0065","doi-asserted-by":"crossref","first-page":"848","DOI":"10.4049\/jimmunol.176.2.848","article-title":"Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3","volume":"176","author":"Watanabe","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2022.110449_bb0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-065X.2000.17712.x","article-title":"Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines","volume":"177","author":"Sotsios","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellsig.2022.110449_bb0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.103.062620","article-title":"Dual regulation of TNFa-induced CCL2 expression in vascular smooth muscle cells by NF\u03baB and AP1","volume":"309","author":"Chen","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2022.110449_bb0080","first-page":"15684","article-title":"Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110449_bb0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bcp.2007.06.019","article-title":"Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5","volume":"74","author":"Leach","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2022.110449_bb0090","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1038\/ncomms7074","article-title":"Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation","volume":"6","author":"Yu","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2022.110449_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2022.110449_bb0100","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.cellsig.2006.02.004","article-title":"Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+\/calmodulin in PTEN-negative U-87MG human glioblastoma cells","volume":"18","author":"Shin","year":"2006","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0105","article-title":"Ratiometric analysis of fura red by flow cytometry: a technique for monitoring intracellular calcium flux in primary cell subsets","volume":"10","author":"Wendt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2022.110449_bb0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pnpbp.2017.04.012","article-title":"Clozapine reduces toll-like receptor 4\/NF-kappaB-mediated inflammatory responses through inhibition of calcium\/calmodulin-dependent Akt activation in microglia","volume":"81","author":"Jeon","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.cellsig.2022.110449_bb0115","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.biocel.2013.04.003","article-title":"Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-kappaB and activator protein-1","volume":"45","author":"Deng","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110449_bb0120","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1302779","article-title":"The Fli-1 transcription factor regulates the expression of CCL5\/RANTES","volume":"193","author":"Lennard Richard","year":"2014","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cellsig.2022.110449_bb0125","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/emboj\/cdg332","article-title":"Evidence that reactive oxygen species do not mediate NF-kappaB activation","volume":"22","author":"Hayakawa","year":"2003","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110449_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110449_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naive, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110449_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.10.4.515","article-title":"Targeting the dopamine D2 receptor in schizophrenia","volume":"10","author":"Seeman","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110449_bb0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jnc.13582","article-title":"Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies","volume":"137","author":"Lukasiewicz","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0150","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1038\/s41598-021-82667-6","article-title":"Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors","volume":"11","author":"Robichon","year":"2021","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.cellsig.2022.110449_bb0155","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1074\/jbc.M114.596098","article-title":"Biased signaling at chemokine receptors","volume":"290","author":"Corbisier","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110449_bb0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.it.2014.02.004","article-title":"Bias in chemokine receptor signalling","volume":"35","author":"Zweemer","year":"2014","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110449_bb0165","first-page":"3109","article-title":"Possible mechanism of CCL2-induced Akt activation in prostate cancer cells","volume":"29","author":"Mizutani","year":"2009","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110449_bb0170","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110449_bb0175","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cellsig.2008.11.015","article-title":"Function of Akt\/PKB signaling to cell motility, invasion and the tumor stroma in cancer","volume":"21","author":"Chin","year":"2009","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110449_bb0180","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4049\/jimmunol.1400825","article-title":"Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis","volume":"193","author":"Stoolman","year":"2014","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110449_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104430","article-title":"Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis","volume":"9","author":"O'Sullivan","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110449_bb0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","article-title":"Effects of clozapine on plasma cytokine and soluble cytokine receptor levels","volume":"16","author":"Pollmacher","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2022.110449_bb0195","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/JCP.0000000000000387","article-title":"The effect of clozapine on hematological indices: a 1-year follow-up study","volume":"35","author":"Lee","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of Inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/03007990152673864","article-title":"Focus on clozapine","volume":"17","author":"Naheed","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cellsig.2022.110449_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1479-5876-12-203","article-title":"Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics","volume":"12","author":"Li","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2022.110449_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.cellsig.2022.110449_bb0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2007.01.019","article-title":"Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro","volume":"92","author":"Kato","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11481-011-9309-0","article-title":"Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation","volume":"7","author":"Hu","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2022.110449_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-5728(00)00351-9","article-title":"Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression","volume":"110","author":"Fischer","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12974-020-01890-6","article-title":"Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines","volume":"17","author":"Murphy","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.cellsig.2022.110449_bb0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0245","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000501187","article-title":"Expression of dopamine receptors in immune regulatory cells","volume":"26","author":"Arce-Sillas","year":"2019","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110449_bb0250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00702-016-1640-4","article-title":"Dopamine, T cells and multiple sclerosis (MS)","volume":"124","author":"Levite","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2022.110449_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2009.07.018","article-title":"Role of dopamine in the physiology of T-cells and dendritic cells","volume":"216","author":"Pacheco","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.cellsig.2022.110449_bb0260","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1074\/jbc.RA118.004682","article-title":"The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface","volume":"294","author":"Schrader","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2022.110449_bb0265","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2018.00571","article-title":"Dopaminergic stimulation of myeloid antigen-presenting cells attenuates signal transducer and activator of transcription 3-activation Favouring the development of experimental autoimmune encephalomyelitis","volume":"9","author":"Prado","year":"2018","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.cellsig.2022.110449_bb0270","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","article-title":"Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study","volume":"132","author":"McKenna","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.cellsig.2022.110449_bb0275","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/RRS-200029981","article-title":"Dopamine receptor signaling","volume":"24","author":"Neve","year":"2004","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2022.110449_bb0285","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1471-4159.2011.07494.x","article-title":"In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry","volume":"119","author":"Park","year":"2011","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110449_bb0290","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0143-4160(03)00149-0","article-title":"Regulation by clozapine of calcium handling by rat submandibular acinar cells","volume":"34","author":"Pochet","year":"2003","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2567.2004.02005.x","article-title":"The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata","volume":"114","author":"Ivanoff","year":"2005","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0300","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/eji.200324166","article-title":"Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways","volume":"34","author":"Tian","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2022.110449_bb0305","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.4049\/jimmunol.172.11.6715","article-title":"Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway","volume":"172","author":"Ogilvie","year":"2004","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cellsig.2022.110449_bb0310","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1182\/blood-2007-11-125039","article-title":"CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR\/4E-BP1","volume":"111","author":"Murooka","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0315","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110449_bb0320","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.molimm.2006.09.033","article-title":"Chemokine-mediated inflammation: identification of a possible regulatory role for CCR2","volume":"44","author":"O\u2019Boyle","year":"2007","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.cellsig.2022.110449_bb0325","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s12035-016-9904-4","article-title":"The atypical antipsychotic agent, clozapine, protects against corticosterone-induced death of PC12 cells by regulating the Akt\/FoxO3a signaling pathway","volume":"54","author":"Zeng","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110449_bb0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/emm.2007.39","article-title":"Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex","volume":"39","author":"Roh","year":"2007","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110449_bb0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1461145706006547","article-title":"Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics","volume":"10","author":"Li","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"23","key":"10.1016\/j.cellsig.2022.110449_bb0340","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00213-014-3608-0","article-title":"The activation of the Akt\/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect","volume":"231","author":"Smith","year":"2014","journal-title":"Psychopharmacology"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682200211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682200211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:09:38Z","timestamp":1760267378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682200211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":68,"alternative-id":["S089865682200211X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110449","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine reduces chemokine-mediated migration of lymphocytes by targeting NF-\u03baB and AKT phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110449"}}